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ABSTRACT
Background: Mucus hypersecretion from airway epithelium is a characteristic feature of severe asthma.
Glucocorticoids (GCs) may suppress mucus production and diminish the harmful airway obstruction. We in-
vestigated the ability of GCs to suppress mRNA expression and protein synthesis of a gene encoding mucin,
MUC5AC, induced by transforming growth factor (TGF)-α in human mucoepidermoid carcinoma (NCI-H292)
cells and the molecular mechanisms underlying the suppression.
Methods: We determined if GCs such as dexamethasone (DEX), budesonide (BUD), and fluticasone (FP)
could suppress MUC5AC production induced by a combination of TGF-α and double-strand RNA, polyinosinic-
polycytidylic acid (polyI:C). MUC5AC mRNA expression and MUC5AC protein production were evaluated. The
signaling pathways activated by TGF-α and their inhibition by GCs were tested using a phosphoprotein assay
and MUC5AC promoter assay.
Results: DEX significantly suppressed the expression of MUC5AC mRNA and MUC5AC protein induced by
TGF-α. The activation of the MUC5AC promoter by TGF-α was significantly inhibited by DEX. DEX did not af-
fect activation of downstream pathways of the EGF receptor or mRNA stability of MUC5AC transcripts. DEX,
BUD, and FP suppressed MUC5AC protein expression induced by a combination of TGF-α and polyI:C in a
dose-dependent manner.
Conclusions: GCs inhibited MUC5AC production induced by TGF-α alone or a combination of TGF-α and
polyI:C; the repression may be mediated at the transcriptional but not post-transcriptional level.
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INTRODUCTION
Excessive mucus production, which contributes to
sputum accumulation and resultant airway obstruc-
tion, is a major clinical manifestation of chronic air-
way inflammatory diseases such as asthma. As is ob-
served in patients with asthma, goblet cell hyperpla-
sia is accompanied by changes in stored and secreted
mucin, which leads to mucus hypersecretion.1,2 Re-
cent studies have revealed an important role of the
epidermal growth factor receptor (EGFR) and its
ligands in goblet cell hyperplasia in asthma pa-
tients.3-5 The critical ligand for the EGFR is trans-
forming growth factor (TGF)-α, which is released
from neutrophils or from the airway epithelium itself.
An increasing body of evidence indicates that EGFR
activation plays an essential role in asthma patho-
genesis.4
Viral infection by viruses such as human rhinovi-
rus, respiratory syncytial virus, influenza virus, and
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human metapneumovirus induces hypersecretion of
mucus and exacerbates asthma.6,7 Among such vi-
ruses, certain RNA viruses synthesize double-
stranded (ds) RNA during replication in infected
cells.8 In a previous study, we have shown that a
synthetic analog of viral dsRNA, polyinosinic-
polycytidylic acid (polyI:C), does not induce the pro-
duction of the mucin MUC5AC itself, but synergisti-
cally induces it in combination with TGF-α.8 These
findings may help explain the excessive production of
mucus in asthmatic patients during viral infection.
Glucocorticoids (GCs) are first-line drugs for con-
trolling airway inflammation in asthmatic patients.
GCs can suppress the mucus hypersecretion associ-
ated with airway inflammation and alleviate the asso-
ciated detrimental clinical manifestations during an
asthmatic attack.3 The mechanism of GC-mediated in-
hibition of mucus hypersecretion is mainly thought to
be secondary to the anti-inflammatory properties of
GCs. Alternatively, GCs may inhibit mucus produc-
tion by their direct action on airway epithelial cells. In
fact, it has been demonstrated that dexamethasone
(DEX) inhibits the expression and production of
MUC2 and MUC5AC in cells of the lung cancer cell
line NCI-H2929 in a resting state. DEX has been
shown to repress MUC5AC expression at the tran-
scriptional level.10 Previous studies have investigated
the effect of GCs on unstimulated epithelial cells or
tissues.9,10 Recently, it has been shown that DEX can
inhibit expression of MUC5AC mRNA induced by
TGF-α in NCI-H292 cells.11 However, little is known
about the effect of GCs on mucin production induced
by stimuli such as growth factors and viral infection,
which mimic airway inflammation.
We hypothesized that the production of MUC5AC
mucin by TGF-α and polyI:C in human airway epithe-
lial cells (NCI-H292) could be repressed with DEX or
inhaled GCs, including budesonide (BUD) and flu-
ticasone (FP), which are used in asthma treatment. In
the present study, we investigated the mechanisms
whereby DEX regulates mucin genes induced by
TGF-α in NCI-H292 cells.
METHODS
CELL CULTURE AND STIMULATION
A human pulmonary mucoepidermoid carcinoma cell
line (NCI-H292) was maintained in RPMI 1640 me-
dium supplemented with 10% fetal bovine serum
(FBS), penicillin (100 UmL), and streptomycin (100
μgmL) at 37℃ in a humidified atmosphere with 5%
CO2. NCI-H292 cells were seeded into 12-well plates
for the ELISA and luciferase assay and into 6-cm
dishes for mRNA analysis. Cells were grown until 70%
confluence and were maintained overnight in serum-
free medium before stimulation. The cells were ex-
posed to TGF-α (R&D Systems, Minneapolis, MN,
USA) at 4 or 40 ngmL with or without polyI:C
(Sigma-Aldrich, St. Louis, MO, USA) at 25 μgmL;
cells were pretreated with dexamethasone (DEX, 10−6
to 10−10 M) (Sigma-Aldrich), BUD (10−9 to 10−13 M)
(Astra-Zeneca, Osaka, Japan), or FP (10−9 to 10−13 M)
(Sigma-Aldrich).
ANALYSIS OF MUCIN BY ELISA
MUC5AC protein was measured as previously de-
scribed.5 In brief, supernatants were collected 24 h
after stimulation, and 50 μL of each sample was incu-
bated overnight with bicarbonate buffer (50 μL) at
40℃ in a 96-well plate (Nunc AS, Roskilde, Den-
mark). Plates were washed 3 times with PBS and
blocked with 2% bovine serum albumin (BSA) for 1 h
at 37℃. The plates were again washed 3 times with
PBS and then incubated with 50 μL of mouse mono-
clonal anti-MUC5AC antibody (1 : 100) (Lab Vision-
Neomarkers, Fremont, CA, USA), which was diluted
with PBS containing 0.05% Tween 20 and dispensed
into each well. After 1 h, the plates were washed
3 times with PBS, and 100 μL of horseradish per-
oxidase-sheep anti-mouse IgG conjugate (1 : 10,000)
(Amersham Biosciences, Buckinghamshire, UK) was
added to each well. After 1 h, the plates were washed
3 times with PBS. Color was developed with 3,3’,5,5’-
tetramethylbenzidine (TMB) peroxidase solution
(Kirkegaard & Perry Laboratories, Gaithersburg,
MD, USA), and the reaction was stopped with 1 M
H2SO4. The data are expressed as fold induction on
the same experimental day as mucin production with
cell passage in NCI-H292 cells.
REAL-TIME QUANTITATIVE PCR ANALYSIS
The expression ofMUC5ACmRNA in NCI-H292 cells
was determined by reverse transcription (RT), fol-
lowed by real-time quantitative PCR. Total RNA was
extracted from lysates of NCI-H292 cells by using Iso-
gen (Nippon Gene, Tokyo, Japan) at 12 h after stimu-
lation. Reverse transcription was performed with 1 μg
of total RNA and oligo (dT) primers in a 25-μL reac-
tion mixture using the High Capacity cDNA Reverse
Transcription Kit, according to the manufacturer’s
protocol (Applied Biosystems, Branchburg, NJ,
USA). The sequences of the specific primer sets that
were used for PCR are listed in Table 1.12,13 Real-time
PCR was performed with an ABI Prism 7900HT se-
quence detection system (PE Applied Biosystems,
Foster City, CA, USA) using the SYBR Green PCR
Master Mix (Applied Biosystems). For MUC5AC and
β-actin, initial denaturation was done at 95℃ for 10
min, followed by 40 cycles of denaturation at 95℃ for
15 s, and annealing and extension at 60℃ for 1 min.
The threshold cycle (CT) was recorded for each sam-
ple to reflect the level of mRNA expression. A valida-
tion experiment confirmed the linear dependence of
the CT value on the concentrations of MUC5AC and
β-actin and the consistency of ΔCT (ΔCT = mean CT
β-actin - mean CT MUC5AC) in a given sample at dif-
ferent RNA concentrations. Therefore, ΔCT was used
GCs Repress Mucin Induction
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Table　1　Primers used for quantitative real-time polymerase chain reaction analysis of gene expression
Target mRNA Forward Primer (5’ to 3’) Reverse Primer (3’ to 5’)
MUC5AC TCA CAG CCG GGT ACG CGT TGG CAC AAG TGG TGC TAT GCC CTG TGT AGC CAG GAC TGC
β-actin GTG GGG CGC CCC AGG CAC CA CTC CTT AAT GTC ACG CAC GAT TTC
EGFR TGC GTC TCT TGC CGG AAT GGC TCA CCC TCC AGA AGG TT
Abbreviations: mRNA, messenger RNA; EGFR, epidermal growth factor receptor.
as an indicator of relative mRNA expression. To de-
termine the effects of different stimuli on MUC5AC
gene expression compared with unstimulated cells,
ΔΔCT was calculated (ΔΔCT = ΔCT stimulus - ΔCT
unstimulated cells). MUC5AC mRNA was indexed
to β-actin using the formula 1(2ΔCT) × 100%; 2ΔΔCT
was calculated to demonstrate the fold change of
MUC5AC gene expression in stimulated cells relative
to that of unstimulated ones. The expression of EGFR
mRNA in NCI-H292 cells was determined in the same
manner.
REPORTER ASSAY FOR THE MUC5AC PRO-
MOTER
To investigate the effects of DEX (10−7 to 10−9 M) on
MUC5AC promoter activity induced by TGF-α, the
humanMUC5AC promoter region (1330 bp upstream
of the transcriptional start site; pGL3-MUC5AC1330)
was cloned from human genomic DNA into the pGL3-
Basic luciferase plasmid (Promega, Madison, WI,
USA) using standard DNA ligation techniques.14
The truncated forms pGL3-MUC5AC192 and pGL3-
MUC5AC63, containing -192 and -63 bp upstream of
the transcriptional start site, respectively, were also
constructed by restriction enzyme digestion.
NCI-H292 (0.8 × 105) cells were seeded into 12-well
plates and grown overnight in complete medium. At
60% confluence, cells were rinsed and incubated for 1
h with 1 mL of serum-free medium. Then, the cells
were transfected with 4 μg of pGL3-MUC5AC using
1.3 μL of Fugene 6 (Roche Applied Science, Indian-
apolis, IN, USA) in 50 μL of RPMI medium. After 12
h, the cells were stimulated with TGF-α (40 ngmL).
The cells were then lysed, and luciferase activity was
determined using a Luciferase Assay Kit (Promega).
The total protein concentration of samples was meas-
ured by spectrophotometry (Nanodrop, Wilmington,
DE, USA) to adjust for variations in cell harvesting.
PHOSPHOPROTEIN ASSAY
Protein phosphorylation was determined using the
Bioplex Phosphoprotein Assay (Bio-Rad, Herculues,
CA, USA). Briefly, NCI-H292 cells (3.0 × 105) were
seeded into 6-cm dishes and treated with TGF-α for
15 min. Protein lysates were prepared using a cell
lysis kit (Bio-Rad); phosphorylated EGFR, ERK,
p38MAPK, JNK, CREB, and NF-κB were detected us-
ing the appropriate assay kit (Bio-Rad) and the Phos-
phoprotein Testing Reagent kit (Bio-Rad) according
to the manufacturer’s protocol. Briefly, 50 μL of cell
lysate (adjusted to a protein concentration of 200-400
μgmL) was plated into a 96-well filter plate coated
with the appropriate antibody-coupled beads and in-
cubated overnight on a platform shaker at 300 rpm at
room temperature. Then, 25 μL of detection antibody
(1×) was added and incubated for 30 min.
Streptavidin-PE (50 μL; 1×) was added and incubated
for 10 min in the dark. The phosphoproteins of
EGFR, MAPKs, CREB, and NF-κB were analyzed by
a Luminex 100TM analyzer (Bio-Rad).
STATISTICAL ANALYSIS
All data are expressed as the mean ± SD. Results
were analyzed using the Student’s t-test or ANOVA as
appropriate. Analyses were performed with SPSS II
software (SPSS Japan, Tokyo, Japan); P values less
than 0.05 were considered significant.
RESULTS
DEXAMETHASONE INHIBITS MUC5AC mRNA
EXPRESSION AND PROTEIN PRODUCTION
We first examined the effects of TGF-α on MUC5AC
production in human mucoepidermoid NCI-H292
cells. Stimulation with TGF-α (40 ngmL) signifi-
cantly increased MUC5AC mRNA expression (Fig.
1A) and MUC5AC protein production (Fig. 1B) com-
pared with that of unstimulated cells as was previ-
ously observed.8 We next investigated the effects
of DEX (10−7 to 10−9 M) on MUC5AC production
induced by TGF-α. DEX significantly suppressed
MUC5AC mRNA expression and protein production
induced by TGF-α (Fig. 1A, B) at 10−7 M, while it
did not affect the basal level of MUC5AC mRNA or
MUC5AC protein. The range of DEX concentrations
used approximates the glucocorticoid levels in the
airway epithelium microenvironment after aerosol de-
livery of glucocorticoids.15 The highest concentration
(10−7 M) did not affect the viability of the cells (data
not shown). The time-course study also demon-
strated that DEX (10−7 M) completely inhibited TGF-
α-induced MUC5AC mRNA expression from 12 to 36
h after stimulation (Fig. 1C). In addition, the protein
production of MUC5AC was significantly inhibited in
the presence of DEX from 24 to 48 h after stimulation
(Fig. 1D). Taken together, these results clearly dem-
onstrate that DEX can directly repress TGF-α-
induced MUC5AC gene expression and protein pro-
duction in airway cells without the presence of inflam-
Takami S et al.
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Fig.　1　MUC5AC mRNA Expression and Protein Production. (A) Effects of dexamethasone (DEX) on TGF-α-in-
duced MUC5AC mRNA expression in NCI-H292 cells (n = 6). MUC5AC mRNA expression 24 h after incubation 
with TGF-α (40 ng/mL) and/or DEX (10−7 to 10−9 M) was analyzed by quantitative real-time PCR. Expression lev-
els of MUC5AC mRNA were normalized to β-actin and expressed as the relative quantity to unstimulated con-
trols. Data are presented as the mean ± SD of 6 independent experiments. (B) Effects of DEX on TGF-α-induced 
MUC5AC protein production in NCI-H292 cells (n = 6). Cells were incubated without or with TGF-α (40 ng/mL) 
and/or DEX (10−7 to 10−9 M) for 24 h. The concentration of MUC5AC protein in the medium was analyzed by ELI-
SA. Data are presented as the mean ± SD of 6 independent experiments. (C and D) Time-course of the effect of 
DEX (10−7 M) on MUC5AC mRNA expression (C) and protein production (D) induced by TGF-α (40 ng/mL) in 
NCI-H292 cells (n = 6). Data were normalized to β-actin (C) and are shown as the mean ± SD of 6 independent 
experiments (C and D). DEX signifi cantly suppressed TGF-α-induced MUC5AC mRNA expression and protein 
production at 12 h and 24 h after stimulation, respectively. *P < 0.05 compared with unstimulated control cells; 
**P < 0.05.
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DEX DOES NOT AFFECT EGFR mRNA EXPRES-
SION AND PHOSPHORYLATION OF EGFR
To obtain mechanistic insight into the inhibitory roles
of DEX on TGF-α-induced MUC5AC production, we
examined the involvement of EGFR activation in the
inhibition of MUC5AC mucin production by DEX.
EGFR has been shown to play a critical role in TGF-
α-induced MUC5AC mucin production via ligand-
dependent transactivation in NCI-H292 cells.5 We
first determined EGFR mRNA expression by quanti-
tative real-time RT-PCR. As shown in Figure 2A, DEX
did not affect EGFR mRNA expression, suggesting
that DEX is not involved in the expression of EGFR.
Since the phosphorylation of EGFR is essential for its
signal transduction, we next tested phosphorylation
of EGFR by the Bioplex Phosphoprotein Assay. TGF-
α dramatically induced the phosphorylation of EGFR
within 15 min after stimulation, but DEX did not af-
fect the phosphorylation (Fig. 2B). These results sug-
gest that DEX inhibits MUC5AC production through
other mechanisms than inhibition of EGFR phospho-
rylation.
GCs Repress Mucin Induction
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Fig.　2　Effect of DEX on EGFR mRNA Expression and Phospho-EGFR. (A) EGFR mRNA ex-
pression was determined by quantitative real-time PCR 12 h after incubation with TGF-α (40 ng/
mL) and/or DEX (10−7 M). The fold expression compared to controls was obtained after normal-
ization to β-actin. Data are presented as the mean ± SD of 6 independent experiments. (B) Quan-
tifi cation of phosphorylated EGFR in NCI-H292 cells treated with TGF-α with or without DEX. 
NCI-H292 cell lysates 15 min after TGF-α (40 ng/mL) treatment with or without DEX (10−7 to 10−9 
M) were tested for the quantifi cation of phosphorylated EGFR by using the Bio-Plex phosphopro-
tein assay kit using the Bio-Rad Luminex machine. The values plotted show phosphorylated 
EGFR levels expressed as the fold increase over unstimulated control (n = 6). *P < 0.05 com-
pared with unstimulated control cells.
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ERK AND CREB ARE ACTIVATED BY TGF-α,
WHICH IS NOT SUPPRESSED BY DEX
Since EGFR activation is essential for TGF-α to in-
duce MUC5AC but DEX did not affect phosphoryla-
tion of EGFR, we reasoned that DEX could inhibit
downstream signaling pathways of EGFR. To deter-
mine which signaling pathways are activated by TGF-
α, we investigated the phosphorylation of ERK12,
p38MAPK, JNK, CREB, and NF-κB, after treating
cells with TGF-α, using the Bioplex Phosphoprotein
Assay. We found that TGF-α activated ERK12 and
CREB, but not p38MAPK, JNK, or NF-κB (Fig. 3A).
However, DEX (10−7 to 10−9 M) did not inhibit the
phosphorylation of ERK12 or CREB (Fig. 3B, C) at
15 min after stimulation.
TRANSIENT TRANSFECTION AND LUCIFERASE
ASSAY
Since DEX did not affect the activation of EGFR or its
downstream signaling pathways, we next analyzed
the effects of DEX directly on the transcriptional
activity of the MUC5AC promoter. TGF-α
(40 ngmL) activated pGL3-MUC5AC1330 and
pGL3-MUC5AC192 (Fig. 4A, B), but not pGL3-
MUC5AC63 (Fig. 4C). DEX (10−8 or 10−9 M) signifi-
cantly inhibited pGL3-MUC5AC1330 activation
(Fig. 4A). DEX (10−7 M) alone did not affect basal
MUC5AC promoter activity (Fig. 4A), which is consis-
tent with endogenous mRNA expression (Fig. 1A).
Taken together with the data from the signaling path-
ways above, these data suggest that DEX specifically
suppresses MUC5AC promoter activation rather than
inhibiting signaling pathways. The inhibition is less
apparent with pGL3-MUC5AC192 (Fig. 4B), indicat-
ing that inhibitory elements reside between the -192
to -1330 region in the promoter (Fig. 4). It is worth
noting that the inhibition of pGL3-MUC5AC1330 acti-
vation by DEX is partial (Fig. 4A). These data suggest
that DEX inhibits MUC5AC mRNA expression not
only at a transcription level, but also through other
mechanisms such as stability of mRNA, since endo-
genous mRNA levels were completely repressed
by DEX (10−7 M) (Fig. 1A). We hypothesized that
DEX might affect post-transcriptional regulation of
MUC5AC. We analyzed the effect of DEX on the sta-
bility of MUC5AC transcripts. The decay in MUC5AC
transcripts was monitored by the inhibition of tran-
scription by actinomycin D (ACD) 8 h after stimula-
tion by TGF-α (40 ngmL) with or without DEX (10−7
M). The rates of MUC5AC mRNA degradation after
ACD exposure were similar between cells with or
without DEX (data not shown), suggesting that DEX
Takami S et al.
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Fig.　3　Phosphorylation of ERK1/2, p38MAPK, JNK, CREB, and NF-κB in the EGFR Signaling 
Pathway and the Effect of DEX. (A) Phosphorylated ERK1/2, p38MAPK, JNK, CREB, and NF-κB 
in NCI-H292 cell lysates collected 15 min after incubation with TGF-α (40 ng/mL) were quantifi ed 
by the Bio-Plex phosphoprotein assay kit. The values plotted show the phosphoprotein level ex-
pressed as the fold increase over unstimulated controls (n = 6). *P < 0.01 compared with unstimu-
lated controls. (B and C) Effects of DEX (10−7 to 10−9 M) on the phosphorylation of CREB (B) and 
ERK1/2 (C) induced by TGF-α in NCI-H292 cells (n = 6).
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did not affect the stability of MUC5AC mRNA, which
is consistent with a previous study.10
DEX, BUD, AND FP INHIBITMUC5ACmRNA AND
PROTEIN PRODUCTION INDUCED BY TGF-α
AND POLYI:C
In clinical situations, viral airway infection is known
to cause enhanced mucin secretion. We have previ-
ously shown that polyI:C mimics viral RNA by syner-
gistically inducing mucin secretion in the presence
of TGF-α, while polyI:C alone does not induce
MUC5AC expression.8 We investigated whether the
synergistic induction could be repressed with ster-
oids, including BUD and FP, which are commonly
used in asthma treatment. As expected, polyI:C (25
μgmL) alone did not significantly induce MUC5AC
protein production, but it strongly enhanced the ef-
fects of TGF-α (Fig. 5A). Co-incubation with DEX,
BUD, or FP suppressed the production of MUC5AC
protein induced by TGF-α and polyI:C in H292 cells
in a dose-dependent manner (Fig. 5A, B, C). These
data demonstrate that DEX, BUD, and FP can
directly repress MUC5AC mRNA expression or
MUC5AC protein production in airway cells during
inflammation and viral infection.
DISCUSSION
In the present study, we found that GCs suppressed
MUC5AC gene expression and MUC5AC protein
production induced by TGF-α in the epidermoid cell
line NCI-H292. Furthermore, BUD and FP, com-
monly used clinically as inhaled GCs, also sup-
pressed MUC5AC protein production induced by
TGF-α and polyI:C, which represents the virus infec-
tion model.8 Activation of EGFR, the main receptor
for TGF-α, and downstream signaling pathways were
not inhibited by DEX, while MUC5AC promoter
activity was suppressed. In addition, the stability of
GCs Repress Mucin Induction
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Fig.　4　Promoter Activity of MUC5AC. Effects of DEX (10−7-10−9 M) on TGF-α (40 ng/mL)-induced activa-
tion of the full-length (pGL-MUC5AC1330) and deletion mutants (pGL-MUC5AC192 and pGL-MUC5AC63) 
of the MUC5AC promoter in NCI-H292 cells. Cells were stimulated with TGF-α with or without DEX for 8 h 
before the lysates were collected. Data are shown as the mean ± SD of 6 independent experiments. *P < 
0.05 compared with unstimulated control cells; **P < 0.05.
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MUC5AC mRNA was not affected by DEX. We con-
cluded that the repression ofMUC5AC expression by
DEX in airway epithelial cells is at least in part regu-
lated at the transcriptional level.
Mucin hypersecretion and goblet cell hyperplasia
are characteristic features of airway obstructive dis-
eases such as asthma.1 Since hypersecretion of mu-
cus is associated with abnormal epithelial cell growth
and differentiation, both inflammatory mediators and
growth factors may be involved in the stimulation of
mucin production from goblet cells.3 It has been re-
ported that GCs suppress MUC5AC mRNA expres-
sion, which was initially reported in NCI-H292 cells9
and later in another respiratory tract-derived cancer
cell line, A549.16 In addition, Chen and coworkers
found that DEX repressed MUC5AC mRNA expres-
sion in primary differentiated NHBE cells.10 How-
ever, these results were obtained from cells at steady-
state equilibrium. In the present study, we have
shown that the induction of MUC5AC mucin produc-
tion and mRNA expression by TGF-α was suppressed
by DEX at a concentration (10−7 M) that is within the
range estimated for GC levels in human lung epithe-
lium after aerosol delivery.17 This result is consistent
with the previous observations made by Nishimoto
et al..11 We also showed that DEX did not inhibit
MUC5AC mRNA expression and MUC5AC protein
production at steady-state equilibrium. This discrep-
ancy from previous findings may be explained by the
different methodology used. Chen et al. quantified
MUC5AC and cyclophilin mRNA levels by northern
blot analysis and did not measure MUC5AC protein
production.10
Previous studies have demonstrated that both NCI-
H292 and NHBE cells share key components of the
signaling pathways downstream of EGFR, which are
responsible for mucin production.18 Therefore, we
hypothesized that NCI-H292 cells would provide a
valid model of mucin production in normal cells, and
thus, focused on investigating the mechanisms of the
signaling pathway using NCI-H292 cells. We exten-
sively studied the downstream signaling of EGFR and
found that ERK and CREB were activated by TGF-α
(Fig. 3A). These data are in partial agreement with
previous findings reported by Hewson and coworkers
that showed increased production of MUC5AC mucin
protein after activation of the EGFR signaling path-
way, which was exclusively dependent on MEK
ERK.14 However, we found that DEX did not affect
the TGF-α-induced phosphorylation of ERK or CREB.
The GC-glucocorticoid receptor (GR) complex can af-
fect the activation of transcription factors, including
NF-κB. However, our results suggest that NF-κB was
not activated by TGF-α, indicating that DEX repres-
Takami S et al.
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Fig.　5　Effect of DEX, BUD, and FP on MUC5AC Protein Production Induced by a Combination of TGF-α 
and PolyI:C. Effects of DEX (10−7 to 10−9 M) (A), BUD (10−9 to 10−13 M) (B), and FP (10−9 to 10−13 M) (C) on 
polyI:C-(75 μg/mL) and TGF-α-(4 ng/mL)-induced MUC5AC protein production in NCI-H292 cells (n = 6). 
Data are shown as the mean ± SD of 6 independent experiments. *P < 0.05.
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sion of MUC5AC is not mediated by trans-repression
through NF-κB.
In the present study, we used a promoter assay
to demonstrate that DEX suppression of MUC5AC
expression was partly mediated by sequences of
MUC5AC between -1330 to -192 bp upstream of the
transcriptional start site (TSS) (Fig. 4). We have not
performed a detailed analysis to identify sequences
with which GR binds the MUC5AC promoter. Our
findings are consistent with those of a previous study
where Chen and coworkers demonstrated that DEX
transcriptionally repressed the MUC5AC promoter
and GR bound to 2 GRE cis-sites (nucleotides -930
to -912 and -369 to -351 upstream of TSS) in the
MUC5AC promoter.10
Post-transcriptional events are also important in the
regulation of gene expression. Co-incubation of TGF-
α with DEX significantly decreased MUC5AC mRNA
expression. Furthermore, analysis of mRNA stability
by quantitative real-time RT-PCR demonstrated that
DEX did not alter the stability of MUC5AC mRNA.
Accordingly, DEX persistently suppressed MUC5AC
mRNA expression induced by TGF-α without affect-
ing the rate ofMUC5AC mRNA degradation, suggest-
ing that DEX-induced repression of MUC5AC in air-
way epithelial cells is not mediated at the post-
transcriptional level.
We have previously demonstrated that a synthetic
analog of viral dsRNA, polyI:C, synergistically en-
hances the induction of respiratory mucin MUC5AC
through EGFR stimulation by TGF-α in human air-
way epithelial cells, both at the level of mRNA expres-
sion and protein production.8 Since the activation of
EGFR has been implicated in the pathogenesis of
asthma,4,5 these data suggest that viral infection
might synergistically amplify respiratory mucin gene
expression and protein production induced by growth
factors that are involved in the pathogenesis of
asthma.8 In the present study, we found that the syn-
ergistic induction of MUC5AC mucin production by
TGF-α and polyI:C was inhibited by BUD and FP at a
lower concentration than DEX, independent from in-
GCs Repress Mucin Induction
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flammatory cells (Fig. 5B, C). These data might be
relevant to the clinical situation where excessive mu-
cin production caused by viral infection often triggers
the exacerbation of asthma. Our data show that in-
haled GCs can directly suppress the hypersecretion
of mucus from airway epithelial cells caused by viral
infection.
Receptor regulation has an important role in con-
trolling the actions of several mediators. Yamamoto
et al. demonstrated that IL-4-induced production of
eotaxin-3 in the airway epithelium was enhanced by
the upregulation of the IL-4 receptor by IFN-γ.19 In
the present study, we evaluated whether the inhibi-
tory effect of DEX was due to the downregulation of
the EGFR or decreased EGFR phosphorylation. How-
ever, the downregulation of EGFR mRNA expression
or inhibitory effects of phosphorylation of this recep-
tor were not observed by co-incubation with DEX
(Fig. 2).
The molecular mechanisms in the treatment of
asthma by GCs are not completely understood, espe-
cially with respect to how specifically GCs repress
gene expression in each cell type in tissues. An un-
derstanding of how GCs regulate mucin gene expres-
sion in cells exposed to inflammatory mediators or
pathogens is important because inhaled GCs are used
to treat patients with asthma where inflammation and
mucin overproduction are characteristic findings.
Our data suggest that steroids controlMUC5AC gene
expression by cis-repression in respiratory cells in the
presence of TGF-α with or without dsRNA, which
may provide a potential strategy for therapy.
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